Latest Partnerships News

Kingsgate Consolidated Limited celebrates a key production milestone at its Chatree Gold Mine with the 100th gold pour since March 2023, alongside rising head grades and ore volumes exceeding forecasts.

Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.

Viridis Mining and Minerals has raised A$3.5 million through a placement to fund critical development milestones for its Colossus Rare Earth Element project, following a major resource upgrade.

Predictive Discovery Limited has raised A$69.2 million through a strategic placement with the Lundin Family and Zijin Mining, bolstering its financial position to advance the Bankan Gold Project in Guinea.

Canyon Resources has gained government approval for its Inland Rail Facility location in Cameroon, advancing the Minim Martap Bauxite Project with new land allocation and infrastructure plans.

Intelligent Monitoring Group has secured a $122.5 million debt facility with National Australia Bank, halving its interest rate and freeing up capital for growth. This refinancing marks a pivotal step in the company’s strategic expansion plans.

Rhythm Biosciences has fast-tracked the integration of the geneType™ business, restoring full commercial capabilities ahead of schedule and setting the stage for expanded market reach.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.

Athena Resources has appointed Peter Jones as Managing Director and CEO, aiming to leverage his extensive Mid-West iron ore experience to advance the high-grade Byro Magnetite Project.

Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.

Alterity Therapeutics has raised over A$2 million through its U.S. ATM facility and expects nearly A$5.7 million in Australian tax rebates, fueling the advancement of its lead neurodegenerative drug candidate ATH434 following promising Phase 2 results.

Centaurus Metals’ Jaguar Nickel Sulphide Project has been selected to join Brazil’s Climate and Ecological Transformation Investment Platform, opening access to a substantial capital pool aimed at supporting sustainable development and decarbonisation.